Up-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancer

Gastroenterology

Volumn 121, Issue 6, 2001, Pages 1339-1347

  Cianchi, Fabio ^a   Cortesini, Camillo ^a   Bechi, Paolo ^a   Fantappiè, Ornella ^a   Messerini, Luca ^a   Vannacci, Alfredo ^a   Sardi, Iacopo ^a   Baroni, Gianna ^a   Boddi, Vieri ^a   Mazzanti, Roberto ^a   Masini, Emanuela ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYCLOOXYGENASE 2; MESSENGER RNA; PARAFFIN; PROSTAGLANDIN;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; GENE EXPRESSION SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035207130     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.29691     Document Type: Article

References (46)

1. Aspirin use and reduced risk of fatal colon cancer
2. Colorectal cancer and non steroidal antiinflammatory drugs
3. Aspirin and the risk of colorectal cancer in women
4. Aspirin use and risk of fatal cancer
5. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals
6. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
7. Sulindac for polyposis of the colon
8. Sulindac for polyposis of the colon
9. Prostaglandin endoperoxide synthase: Why two isoforms?
10. Eicosanoids and the gastrointestinal tract
11. Altered eicosanoids levels in human colon cancer
12. Piroxicam and other cyclooxygenase inhibitors: Potential for cancer prevention
13. Lipid peroxidation and prostaglandins in colorectal cancer
14. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
15. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
16. Δ716 knock out mice by inhibition of cyclooxygenase 2 (cox-2)
17. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
18. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2
19. 2 in human colon cancer cells
20. 2 inhibits TNF-alpha release via a mechanism involving IL-10
21. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
22. Tumour angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
23. Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer
24. Effects of OKY 046, a thromboxane synthase inhibitor on renal function in non azotemic cirrhotic patients with ascites
25. Protein measurement with the folin phenol reagent
26. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues
27. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats
28. Differential expression of cyclooxygenase-2 in human colorectal cancer
29. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers
30. Role of prostaglandin E1 and copper in angiogenesis
31. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronam
32. The relationship between cyclooxygenase-2 expression and colorectal cancer
33. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer
34. Molecular and biological properties of vascular endothelial growth factor family of proteins
35. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
36. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumour vascularity and liver metastasis
37. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
38. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
39. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers
40. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxigenase-2 inhibitor
41. Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells
42. Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis
43. 2 synthase that acts in concert with cyclooxygenase-2
44. Prostaglandin H synthase, nonsteroidal anti-inflammatory drugs, and colon cancer
45. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential